UK Long COVID Triple Treatment Trial Fails to Show Clinical Benefit in Major 2026 Study
The UK's flagship STIMULATE-ICP long COVID trial has concluded that three repurposed drug regimens—rivaroxaban, colchi...
Read More →The UK's flagship STIMULATE-ICP long COVID trial has concluded that three repurposed drug regimens—rivaroxaban, colchi...
Read More →Jennifer Lopez celebrated her 57th birthday on July 24, 2026, by sharing an uplifting Instagram video set to Theodore Ro...
Read More →Margot Robbie and Tom Ackerley have welcomed their second child, the couple exclusively confirms. Alongside the joyful a...
Read More →Selena Gomez and Benny Blanco have officially married in an intimate, private ceremony in Austin, Texas. The couple, who...
Read More →The pivotal RASolute-302 phase 3 clinical trial has revealed that daraxonrasib, a multi-selective RAS(ON) inhibitor, nea...
Read More →The groundbreaking RIO trial has revealed unprecedented results, demonstrating that long-acting antibodies can sustain H...
Read More →A landmark Phase III clinical trial reveals that the novel RAS(ON) inhibitor daraxonrasib doubles median overall surviva...
Read More →In a landmark medical breakthrough, researchers have successfully utilized autologous stem-cell therapy to restore endog...
Read More →University of Oxford researchers have published groundbreaking Phase II clinical trial results in Nature Medicine, demon...
Read More →Yale School of Medicine researchers have identified two proteins, mGluR4 and NPDC1, that facilitate the spread of misfol...
Read More →A large UK clinical trial published in The Lancet Infectious Diseases demonstrates that repurposed antihistamines and co...
Read More →Cancer Research UK, alongside Cytovation and the Norwegian Cancer Society, has launched a global Phase II trial for adva...
Read More →